Aubrey Joy P Tejada, Michael Angelou L Nada, Ruth Antoinette D Chin, Janna Ysabelle O Casidsid, Joseph B Ancla, Marel Jan G Joloro, Mark Christian C Reterta, Anton Roi G Collado, Sharmen C Berlin, Arra B Asejo, Nikka Mae R Yadao, Virgilio P De Paz, Ursela G Bigol, Rommel J Gestuveo
{"title":"Complete genome sequence of bacteriophages infecting <i>Escherichia</i>, <i>Enterobacter</i>, and <i>Pseudomonas</i> isolates.","authors":"Aubrey Joy P Tejada, Michael Angelou L Nada, Ruth Antoinette D Chin, Janna Ysabelle O Casidsid, Joseph B Ancla, Marel Jan G Joloro, Mark Christian C Reterta, Anton Roi G Collado, Sharmen C Berlin, Arra B Asejo, Nikka Mae R Yadao, Virgilio P De Paz, Ursela G Bigol, Rommel J Gestuveo","doi":"10.1128/mra.01345-24","DOIUrl":null,"url":null,"abstract":"<p><p>We reported six new species of bacteriophages belonging to the genus <i>Drulisvirus</i>, <i>Mosigvirus</i>, <i>Kayfunavirus</i>, and <i>Kagunavirus</i>, with a shared genome similarity of 77.2% to 94.5%. Seven isolates are suitable candidates for phage therapy, thereby expanding our knowledge about biocontrol alternatives against infections caused by multidrug-resistant bacteria.</p>","PeriodicalId":18654,"journal":{"name":"Microbiology Resource Announcements","volume":" ","pages":"e0134524"},"PeriodicalIF":0.7000,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12060664/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbiology Resource Announcements","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1128/mra.01345-24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/1 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
We reported six new species of bacteriophages belonging to the genus Drulisvirus, Mosigvirus, Kayfunavirus, and Kagunavirus, with a shared genome similarity of 77.2% to 94.5%. Seven isolates are suitable candidates for phage therapy, thereby expanding our knowledge about biocontrol alternatives against infections caused by multidrug-resistant bacteria.